FindTrial
Sign In

Action Plan for the Elimination of Malaria Infections in the Grande Comoros

Action Plan for the Elimination of Malaria Infections in the Grande Comoros

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027075
Enrollment
Unknown
Registered
2019-10-30
Start date
2019-11-01
Completion date
Unknown
Last updated
2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

Interventions

Group 1:Artemisinin piperaquine tablets + 4 tablets of primaquine phosphate (adult)
Group 2:Artemisinin piperaquine tablets + 2 tablets of primaquine phosphate (adult)

Sponsors

Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.3 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age: more than 3 months; 2. Sign the informed consent form; 3. Have oral drug ability.

Exclusion criteria

Exclusion criteria: 1. Severe malaria patients who are not eligible to oral; 2. Pregnant women within three months; 3. Infants within 3 months.

Design outcomes

Primary

MeasureTime frame
the parasite rate of asymptomatic carriers;Blood test rate;Mass drug administration coverage;adverse reaction;Pregnant women follow-up survey;Neonatal follow-up survey;Entomological Inoculation Rate;Genetic analysis;Family medicine box system;Health economics assessment;—

Countries

Comoros

Contacts

Public ContactSong Jianping

Guangzhou University of Chinese Medicine

songjp@gzucm.edu.cn+86 020 36585633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026